BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 33688910)

  • 1. Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary.
    Frew JW; Lowes MA; Goldfarb N; Butt M; Piguet V; O'Brien E; Ingram J; Jemec GBE; Tan J; Zouboulis C; Alavi A; Kirby JS
    JAMA Dermatol; 2021 Apr; 157(4):449-455. PubMed ID: 33688910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical Procedural Definitions for Hidradenitis Suppurativa Developed by Expert Delphi Consensus.
    Bui H; Bechara FG; George R; Goldberg S; Hamzavi I; Kirby JS; Saylor D; Sayed CJ
    JAMA Dermatol; 2023 Apr; 159(4):441-447. PubMed ID: 36811866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement.
    Mastacouris N; Tannenbaum R; Strunk A; Koptyev J; Aarts P; Alhusayen R; Bechara FG; Benhadou F; Bettoli V; Brassard A; Brown D; Choon SE; Coutts P; da Silva DLF; Daveluy S; Dellavalle RP; Del Marmol V; Emtestam L; Gebauer K; George R; Giamarellos-Bourboulis EJ; Goldfarb N; Hamzavi I; Hazen PG; Horváth B; Hsiao J; Ingram JR; Jemec GBE; Kirby JS; Lowes MA; Marzano AV; Matusiak L; Naik HB; Okun MM; Oon HH; Orenstein LAV; Paek SY; Pascual JC; Fernandez-Peñas P; Resnik BI; Sayed CJ; Thorlacius L; van der Zee HH; van Straalen KR; Garg A
    JAMA Dermatol; 2023 Nov; 159(11):1258-1266. PubMed ID: 37755725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed Definitions of Typical Lesions in Hidradenitis Suppurativa.
    Daxhelet M; Suppa M; White J; Benhadou F; Thorlacius LR; Jemec GBE; Del Marmol V; Revuz J
    Dermatology; 2020; 236(5):431-438. PubMed ID: 32516781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ABC of Hidradenitis Suppurativa: A Validated Glossary on how to Name Lesions.
    Lipsker D; Severac F; Freysz M; Sauleau E; Boer J; Emtestam L; Matusiak Ł; Prens E; Velter C; Lenormand C; Meyer N; Jemec GB
    Dermatology; 2016; 232(2):137-42. PubMed ID: 26889678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The International Glossary on Infertility and Fertility Care, 2017.
    Zegers-Hochschild F; Adamson GD; Dyer S; Racowsky C; de Mouzon J; Sokol R; Rienzi L; Sunde A; Schmidt L; Cooke ID; Simpson JL; van der Poel S
    Fertil Steril; 2017 Sep; 108(3):393-406. PubMed ID: 28760517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global consensus process to establish a core dataset for hidradenitis suppurativa registries.
    Wainman HE; Chandran NS; Frew JW; Garg A; Gibbons A; Gierbolini A; Horvath B; Jemec GB; Kirby B; Kirby J; Lowes MA; Martorell A; McGrath BM; Naik HB; Oon HH; Prens E; Sayed CJ; Thorlacius L; Van der Zee HH; Villumsen B; Ingram JR
    Br J Dermatol; 2024 Mar; 190(4):510-518. PubMed ID: 37976235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert consensus on priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa: a Delphi consensus study.
    Yamanaka-Takaichi M; Revankar R; Shih T; Gall M; Hsiao JL; Shi VY; Alavi A
    Arch Dermatol Res; 2023 Sep; 315(7):2129-2136. PubMed ID: 36951970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes.
    Mokkink LB; Terwee CB; Patrick DL; Alonso J; Stratford PW; Knol DL; Bouter LM; de Vet HC
    J Clin Epidemiol; 2010 Jul; 63(7):737-45. PubMed ID: 20494804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes.
    Thorlacius L; Ingram JR; Garg A; Villumsen B; Esmann S; Kirby JS; Gottlieb AB; Merola JF; Dellavalle R; Christensen R; Jemec GB
    BMJ Open; 2017 Feb; 7(2):e014733. PubMed ID: 28219961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process.
    Thorlacius L; Ingram JR; Villumsen B; Esmann S; Kirby JS; Gottlieb AB; Merola JF; Dellavalle R; Nielsen SM; Christensen R; Garg A; Jemec GBE;
    Br J Dermatol; 2018 Sep; 179(3):642-650. PubMed ID: 29654696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards consensus in operational definitions in functional capacity evaluation: a Delphi Survey.
    Soer R; van der Schans CP; Groothoff JW; Geertzen JH; Reneman MF
    J Occup Rehabil; 2008 Dec; 18(4):389-400. PubMed ID: 19011956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.
    Zouboulis CC; Tzellos T; Kyrgidis A; Jemec GBE; Bechara FG; Giamarellos-Bourboulis EJ; Ingram JR; Kanni T; Karagiannidis I; Martorell A; Matusiak Ł; Pinter A; Prens EP; Presser D; Schneider-Burrus S; von Stebut E; Szepietowski JC; van der Zee HH; Wilden SM; Sabat R;
    Br J Dermatol; 2017 Nov; 177(5):1401-1409. PubMed ID: 28636793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an international glossary for clinical guidelines collaboration.
    Christensen RE; Yi MD; Kang BY; Ibrahim SA; Anvery N; Dirr M; Adams S; Amer YS; Bisdorff A; Bradfield L; Brown S; Earley A; Fatheree LA; Fayoux P; Getchius T; Ginex P; Graham A; Green CR; Gresele P; Hanson H; Haynes N; Hegedüs L; Hussein H; Jakhmola P; Kantorova L; Krishnasamy R; Krist A; Landry G; Lease ED; Ley L; Marsden G; Meek T; Meremikwu M; Moga C; Mokrane S; Mujoomdar A; Newton S; O'Flynn N; Perkins GD; Smith EJ; Prematunge C; Rychert J; Saraco M; Schünemann HJ; Senerth E; Sinclair A; Shwayder J; Stec C; Tanni S; Taske N; Temple-Smolkin RL; Thomas L; Thomas S; Tonnessen B; Turner AS; Van Dam A; van Doormaal M; Wan YL; Ventura CB; McFarlane E; Morgan RL; Ogunremi T; Alam M
    J Clin Epidemiol; 2023 Jun; 158():84-91. PubMed ID: 37019344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminology of e-Oral Health: Consensus Report of the IADR's e-Oral Health Network Terminology Task Force.
    Mariño RJ; Uribe SE; Chen R; Schwendicke F; Giraudeau N; Scheerman JFM
    BMC Oral Health; 2024 Feb; 24(1):280. PubMed ID: 38419003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Globe and Adnexal Trauma Terminology Survey.
    Hoskin AK; Fliotsos MJ; Rousselot A; Ng SMS; Justin GA; Blanch R; Colyer MH; Shukla B; Natarajan S; Kuhn F; Sundar G; Woreta FA; Watson SL; Agrawal R;
    JAMA Ophthalmol; 2022 Aug; 140(8):819-826. PubMed ID: 35862061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic Review.
    Der Sarkissian S; Hessam S; Kirby JS; Lowes MA; Mintoff D; Naik HB; Ring HC; Chandran NS; Frew JW
    JAMA Dermatol; 2022 Mar; 158(3):300-313. PubMed ID: 35044423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity and Area Score for Hidradenitis (SASH): a novel outcome measurement for hidradenitis suppurativa.
    Kirby JS; Butt M; King T
    Br J Dermatol; 2020 Apr; 182(4):940-948. PubMed ID: 31233623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of the hidradenitis suppurativa clinical response in the assessment of patients with hidradenitis suppurativa.
    Kimball AB; Ganguli A; Fleischer A
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2254-2256. PubMed ID: 29959796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.